Updates in Treating Pediatric Leukemia
Recorded on: May 11, 2022
CE credit available until: May 27, 2023
1.0 CME/CE Credit/Contact Hour for physicians, registered nurses, and social workers.
Format: Non-interactive recorded webinar
Target Audience
This CE activity is intended for oncologists, pediatric hematologist-oncologists, nurses, and oncology social workers involved in the care of patients with hematologic malignancies.
Learning Objectives
After completing this CE activity, the participant should be better able to:
- Describe common childhood blood cancers, including AML and ALL
- Identify signs and symptoms of childhood blood cancers and diagnostic tests
- Explain treatments, including the role of clinical trials, and LLS PedAL, a precision medicine clinical trial for pediatric AML
- Describe management of short- and long-term side effects of treatment, follow-up care plans, and communication between the pediatrician/family physician and oncologist
- Describe psychosocial and survivorship challenges and resources to support children and their families
Speakers
Todd Cooper, DO
Professor of Pediatrics/University of Washington
Evans Family Endowed Chair in Pediatric Cancer
Section Chief of Oncology-Pediatric Oncology
Director of the Pediatric Leukemia/Lymphoma Program
Co-Director of the High-Risk Leukemia Program
Seattle Children's Cancer
Seattle, WA
Kristina Lopez, LCSW, MSW
Information Specialist
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Social Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MLI maintains responsibility for the course.
Social workers completing this course receive 1.0 Cultural Competency continuing education credits.
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Providers
This Activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.
Supporters
There is no commercial support associated with this CE activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.